Investors sold shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) on strength during trading on Tuesday. $60.37 million flowed into the stock on the tick-up and $111.24 million flowed out of the stock on the tick-down, for a money net flow of $50.87 million out of the stock. Of all equities tracked, iShares NASDAQ Biotechnology Index had the 25th highest net out-flow for the day. iShares NASDAQ Biotechnology Index traded up $2.04 for the day and closed at $110.41
The firm has a market cap of $10,290.00, a PE ratio of 3.65 and a beta of 1.38.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 28th. Stockholders of record on Friday, December 22nd were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.45%. This is a boost from iShares NASDAQ Biotechnology Index’s previous quarterly dividend of $0.04. iShares NASDAQ Biotechnology Index’s dividend payout ratio (DPR) is 2.38%.
About iShares NASDAQ Biotechnology Index
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.